BioSpace News Archive

Business

Former Agios Executive to Take Over Deciphera After CEO Steps Down

After five years at the reins, Mike Taylor will step down from his role as president and chief executive officer of Waltham, Mass.-based Deciphera Pharmaceuticals. Taylor’s last day in the role will by March 18, the company announced late Monday.

March 5, 2019
·
2 min read
·
Alex Keown
Drug Development

NextCure and Yale Publish New Immuno-Oncology Target, Siglec-15

New Haven, Conn.-based NextCure and the Yale University Office of Corporate Research (OCR) announced the publication of a study describing Siglec-15 (S15), a new target for immunotherapy. The article was published in the journal Nature Medicine.

March 5, 2019
·
2 min read
·
Mark Terry
Policy

Celgene’s Fedratinib Given Priority Review for Myelofibrosis

The U.S. Food and Drug Administration (FDA) accepted Celgene’s New Drug Application (NDA) for fedratinib for myelofibrosis. It also granted it a Priority Review, with a target action date of September 3, 2019.

March 5, 2019
·
3 min read
·
Mark Terry
Genetown

14 Drugs Earn Billions for These Massachusetts Biotechs

With Boston and the surrounding area being one of the centers of the pharmaceutical world, it should come as no surprise that some of the top-selling medications are based in the Bay State.

March 5, 2019
·
2 min read
·
Alex Keown
Deals

Pacira Snaps up Med Tech Myoscience for $220 Million

San Diego-based Pacira Pharmaceuticals, a specialty pharmaceutical company, plunked down $220 million to acquire medical device company Myoscience and its non-opioid pain treatment system iovera.

March 5, 2019
·
2 min read
·
Alex Keown
Deals

Deep Dive: Bristol-Myers Squibb’s Celgene Acquisition

Bristol-Myers Squibb and Celgene Corporation are strongly urging shareholders to submit their proxy votes as quickly as possible whether they plan to attend the April 12, 2019 Special Meeting or not. The meeting is when the official vote on whether Bristol-Myers Squibb will buy Celgene will take place.

March 5, 2019
·
4 min read
·
Mark Terry
Drug Development

Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema

The study showed that artificial intelligence can be used to provide widespread, cost-effective eye screenings via telemedicine to assist ophthalmologists in improving vision outcomes.

March 5, 2019
·
3 min read
·
Alex Keown
BioForest

Your Feedback Matters! Life Science Resumes

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know if you’ve updated your resume and components that make it competitive.

March 5, 2019
·
1 min read
·
BioSpace Staff
Business

UPDATE: Scott Gottlieb Resigns From Role as FDA Commissioner

Scott Gottlieb, the proactive commissioner of the U.S. Food and Drug Administration has resigned, according to reports. Gottlieb will leave the regulatory agency in about a month.

March 5, 2019
·
4 min read
·
Alex Keown
BioCapital

Lowering Colorectal Cancer Risk with Diet and Lifestyle

Research finds processed meats such as hot dogs increase risk while whole grains lower the risk.

March 5, 2019
·
2 min read